. . . "Research and development spending decreased quarter-to-quarter to $11.5 million or 22.2% of second quarter revenues from 12.5 million or 26.6% of first quarter revenues, as Micrel continued to reduce expenses in all areas, including research and development, while at the same time developing more world-class products." . .